While sepsis-induced hypercoagulability is a recognised complication of severe respiratory infections, most patients with COVID-19 maintain normal concentrations of coagulation factors, with normal prothrombin time, and other coagulation screening tests, and platelet counts, suggesting that COVID-19 induces a unique prothrombotic state [4]. The gene discussed is F2; the disease is COVID-19.